Robotic surgery may replace chemo for testicular cancer
NCT ID NCT05345158
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether robotic surgery can be the first treatment for stage IIA/B testicular seminoma, instead of chemotherapy or radiation. The surgery removes lymph nodes in the abdomen using a robot. The goal is to see if it prevents cancer from coming back. The trial will enroll 25 men.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Robotic retroperitoneal lymph node dissection (R-RPLND) using the DaVinci robotic system
- What this could lead to
- If successful, this could offer a less toxic, surgery-only option for early-stage testicular cancer, reducing the need for chemotherapy or radiation.
- What could go wrong
- This is a small, early-phase study with only 25 participants. The surgery may not control the cancer as well as standard treatments, and relapse remains a risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHADENOPATHY RETROPERITONEAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.